Patient-derived organoids: an emerging platform to de-risk immunotherapy development 

Poster

Tumour organoid and T cell co-cultures to evaluate CAR-T cell cytotoxicity
> Download now

Factsheet

Explore the applications of patient-derived HUB organoids in immuno-oncology drug development 
> Download now